Trials / Completed
CompletedNCT00830115
Pantoprazole 20/40 mg in the Treatment of Symptomatic Reflux Disease With Focus on Sleep Disorders
Efficacy of Pantoprazole in Patients Older Than 12 Years With Reflux Associated Sleep Disorders
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,045 (actual)
- Sponsor
- Nycomed · Industry
- Sex
- All
- Age
- 12 Years
- Healthy volunteers
- Not accepted
Summary
The aim of the study was to evaluate the effect of pantoprazole on sleep disorders in patients with NERD (non-erosive reflux disease) or eGERD (erosive gastroesophageal reflux disease). The prevalence and intensity of the sleep disorders were evaluated by a standardized questionnaire. The study was expected to provide further data on safety and tolerability of pantoprazole.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Pantoprazole | Observational, non-interventional study (NIS). The physician decided about dosage according to individual needs (20 or 40 mg pantoprazole, once daily). |
Timeline
- Start date
- 2009-01-01
- Primary completion
- 2009-05-01
- Completion
- 2009-06-01
- First posted
- 2009-01-27
- Last updated
- 2012-05-08
- Results posted
- 2010-09-15
Locations
201 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT00830115. Inclusion in this directory is not an endorsement.